Considering that PI-3K is upstream of mTOR, and is activated by many microenvironmental cues important for ALL proliferation and survival [8, 22], we considered that inhibition of PI-3K in addition to mTOR would be a superior strategy to inhibition of mTOR alone. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.